MediMabBio
Developer of healthcare immunotherapies designed to treat serious diseases such as cancer and autoimmune disorders. The company offers engineered monoclonal antibodies, cytokine-antibody fusion protei...
Valuation
—
Share Price
N/A
Total Raised
$37.9M
Last Round
N/A
19 investors — free account required
Sign up free Investors
+19 other investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details